Antonio Gutierrez

TL;DR: Deletions affecting codons 557 to 558 are relevant for the prognosis of RFS in GIST patients and should be considered to be a new prognostic stratification variable for randomized trials exploring imatinib mesylate in the adjuvant setting in Gist patients.

TL;DR: Retrospective data shows that peripheral T‐cell lymphoma patients sensitive to conventional chemotherapy for aggressive lymphomas may respond better if this treatment is consolidated with frontline autologous stem cell transplantation (ASCT).

TL;DR: Salvage treatment results with HDC/ASCT in PTCL are similar to those found in corresponding aggressive B-cell lymphomas and the utility of the pre-transplant IPI system in predicting outcome is confirmed.

TL;DR: In a retrospective study with a prolonged follow-up, consolidation with ASCT in CR patients who had presented unfavorable prognostic factors at diagnosis substantially increased the OS and PFS when compared with conventional chemotherapy.

TL;DR: The prognosis of old or immunocompromised patients with refractory or relapsing diffuse large‐cell lymphoma is very poor as the current standard of salvage therapy with autologous stem cell transplantation is not feasible for most of them, so new active regimens with an acceptable toxicity profile are needed.